RecallDepth
Class II Ongoing

Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/320 mg/25 mg, (a) 30-count bottles (NDC 0093-7809-56) & 90-count bottles (NDC 0093-7809-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.

Company
Teva Pharmaceuticals Usa
Recall Initiated
November 27, 2018
Posted
December 19, 2018
Recall Number
D-0310-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
31,079 bottles
Firm Location
North Wales, PA, United States

Reason for Recall

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Distribution

USA Nationwide including Puerto Rico.

Lot / Code Info

All lots within expiry. NDC 0093-7809-56 & NDC 0093-7809-98

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls